Patrick Sullivan Email & Phone Number

Philadelphia, Pa, Us

Boston, Massachusetts, United States

Lead the commercialization efforts of novel CNS therapies to transform the care of ADHD, Alzheimer's and other neurological conditions.

Boston, Massachusetts, United States

Led the brand strategy, go-to market plan and launch of a highly unique CNS therapy precisely designed to advance the care for pediatric, adolescent and adult ADHD patients.

Washington Dc-Baltimore Area

Led the global commercialization plan for EVRENZO, a first in class, new novel mechanism, oral anemia therapy. Advocated for alternative Ex-US launch approach in China to drive early global experience. Played an vital role increasing the value of asset with 4 additional indications with expanded lifecycle management plan in partnership with product strategy team (PST).Key elements: launch strategy, positioning, go-to market execution plan, market shaping initiative, local resourcing requirements, forecast/financials, pre-launch/launch KPIs

Washington Dc-Baltimore Area

Recruited to help launch a new Renal and Hematology franchise globally. This high visibility initiative demanded clarity, independence, high influence skills and collaboration across many people/functions. Key elements & contributions: target therapeutic areas of focus, level of differentiation definition, discernment among development candidates vs in-license approaches and new Business unit integration planThe successful launch aided the rapid acceleration from the incubation stage to making significant scientific, patient and revenue impact within 18-24 months post launch.

Greater Philadelphia Area

Led the Vyvanse growth initiative and plan to accelerate penetration in the pediatric segment (sub-13 years old) and adult expansion across the professional HCP target audience.Spearheaded a new positioning, campaign development and messaging platform in collaboration with Patient/Consumer segment team to successfully launch and implement this plan. Played a key role in NBU portfolio planning team maximize synergies with target segments, shared audiences and ensure to show up as "one" externally.

Greater Philadelphia Area

Goal was to help more Crohns and Colitis patients that results in accelerated growth over $1B+ for GI business. Improving "access" perceptions for Lialda/Pentasa by evolving Payer contracting strategy, refinement of current value proposition and launch new communication platform.

Greater Philadelphia Area

Led the US business with an aim to improve the overall health business by increasing productivity, profitability and contribution to the organization. Restructured the business to deliver ~$160M+ net profit, evolved our product distribution with novel specialty Rx channel (company first) to increase value and developed government ESRD PPS policy interpretation action plan that outlined critical to steps to consider for business impact and implementation.

Greater Philadelphia Area

An international assignment to help accelerate launch uptake in the Global/Int'l markets by leveraging early launch learnings audit, improve consistency of building brands, strengthen competitive differentiation and identification of synergy opportunities.

Led the relaunch initiative and plans for FOSRENOL in the US market. This relaunch effort required a complete reassessment of the initial launch that fueled the repositioning, segmentation, new campaign, messaging and re-launch plan to positively change the performance trajectory.

Greater Philadelphia Area

Responsible for leading the execution of the launch plan for ENTEREG, a first in class, novel mechanism to treat Post-Operative Ileus (POI), specifically launch execution efforts inclusive of pre-launch market shaping plan, launch tactical plan and alliance collaboration with GSK partners. Actively participated in market sizing and competitive assessment for 2nd indication for Opiod Induced Constipation (OIC).

East Hanover, New Jersey, United States

Nominated as talent to join MDP (management development program). Support the repositioning and return the Retina business to growth initiative for VISUDYNE to treat Age Related Macular Degeneration (ARMD) during a period of rampant clinical experimentation and combination use to help patients with blindness.

East Hanover, New Jersey

Responsible for driving the Northeast Region business and lead a team comprised of sales key account managers (KAMs), area managers (AMs) and reimbursement managers (RMs), key account managers & reimbursement managers) to grow VISUDYNE use and procedures in ARMD with Retina physicians and key back of the eye target accounts.

Greater Philadelphia & Mid-Atlantic Areas

Responsible growing diverse brand portfolio and leading team of sales representatives across the greater Philadelphia and Mid-Atlantic areas.

Greater Philadelphia Area

Responsible for growing anti-infective brands, Cipro/Cipro IV, launch Avelox/Avelox IV, launch Viadur oncology implant and Levitra in key community hospitals, teaching institutions, key specialists in local communities across the greater Philadelphia area, Delaware and Maryland.

Greater Phila Area

Healthcare representative covering the greater Philadelphia area calling multi-specialty and acute care HCPs to grow anti-infectives and cardiovascular products. Successfully launched Avelox/Avelox IV, Baycol and Levitra.

Bachelor Of Science In Business Adminstration, Marketing

Mba, Executive Mba In Healthcare Marketing (Currently Active)